Plutux
$125.50
+0.15%
2026-09-03 16:00:03 EDT+$0.19
Healthcare
Medical - Devices
NYSE
활발히 거래 중

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa ...

주가 흐름

$125.50
+0.15%+$0.19
고가
저가
52주 최고-0.5%
거래량비
간격
범위6.3h
거래량SMA5SMA10
Integer Holdings Corporation (NYSE: ITGR) is one of the world's largest medical device contract development and manufacturing organizations (CDMOs), with operations across the United States, Puerto Rico, Costa Rica, and other international regions. Founded in 1970 by Wilson Greatbatch, the inventor of the implantable pacemaker, the company has evolved into ...Integer Holdings Corporation (NYSE: ITGR) is one of the world's largest medical device contract development and manufacturing organizations (CDMOs), with operations across the United States, Puerto Rico, Costa Rica, and other international regions. Founded in 1970 by Wilson Greatbatch, the inventor of the implantable pacemaker, the company has evolved into a comprehensive partner for medical device innovation and outsourcing. Integer's Medical segment offers a broad array of products including cardiac rhythm management devices like pacemakers, defibrillators, and leads; neuromodulation devices such as spinal cord stimulators; and a wide range of surgical instruments for arthroscopic, laparoscopic, and orthopedic procedures. The company also produces critical components like non-rechargeable batteries, feedthroughs, device enclosures, and precision-machined parts. The Non-Medical segment focuses on customized battery power systems for energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs), supporting diverse markets from cardiac to portable medical applications. Financially, Integer has a market cap of approximately $4.25 billion, with revenue per share of $54.14 and a net profit margin of 7%. The company employs over 11,000 people worldwide. Under the leadership of CEO Payman Khales, who assumed the role in October 2025, Integer continues to deliver innovative, cost-effective solutions, maintaining a strong focus on operational excellence and strategic growth. The company's extensive history of 80 years of industry-changing innovations underscores its commitment to enhancing patient lives through high-quality medical technologies.
설립
1970
직원 수
11000
CEO
Payman Khales
정식 명칭
Integer Holdings Corporation
섹터
Healthcare
산업
Medical - Devices
ROE
7.43%
시가총액
$4.26B
유동비율
3.73
WACC
6.60%
ROIC
5.21%

연락처 정보

214 618 5243
5830 Granite Parkway, Plano, TX 75024

관련 종목Medical - Devices

전체 미국 주식 보기

Plutux는 투자자문업자가 아닙니다. 시장 데이터와 AI가 생성한 분석은 정보 제공 및 교육 목적일 뿐 투자 자문이 아닙니다. 면책 조항

© Plutux Technology Limited 2026